Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec;395(12):1463-1475.
doi: 10.1007/s00210-022-02284-6. Epub 2022 Sep 5.

Citicoline and COVID-19: vis-à-vis conjectured

Affiliations
Review

Citicoline and COVID-19: vis-à-vis conjectured

Hayder M Al-Kuraishy et al. Naunyn Schmiedebergs Arch Pharmacol. 2022 Dec.

Abstract

Coronavirus disease 2019 (COVID-19) is a current pandemic disease caused by a novel severe acute respiratory syndrome coronavirus virus respiratory type 2 (SARS-CoV-2). SARS-CoV-2 infection is linked with various neurological manifestations due to cytokine-induced disruption of the blood brain barrier (BBB), neuroinflammation, and peripheral neuronal injury, or due to direct SARS-CoV-2 neurotropism. Of note, many repurposed agents were included in different therapeutic protocols in the management of COVID-19. These agents did not produce an effective therapeutic eradication of SARS-CoV-2, and continuing searching for novel anti-SARS-CoV-2 agents is a type of challenge nowadays. Therefore, this study aimed to review the potential anti-inflammatory and antioxidant effects of citicoline in the management of COVID-19.

Keywords: COVID-19; Citicoline; Neuroinflammation; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Chemical structure of citicoline
Fig. 2
Fig. 2
Neuroprotective effect of citicoline (CTN): CTN, through its anti-inflammatory and antioxidant effects as well as through induction of neurogenesis and neuronal energy, attenuates neurodegeneration and neuroinflammation, respectively. CTN induces expression of silent information regulator 1 (SIRT1), which inhibits neuroinflammation and produces a direct neuroprotective effect. The final effect of CTN is neuroprotection
Fig. 3
Fig. 3
Citicoline reduces SARS-CoV-2-induced neuroinflammation through a silent information regulator 1 (SIRT1)-dependent pathway: citicoline (CTN) increases expression of forkhead box O (Foxo) and adenosine monophosphate protein kinase (AMPK) with inhibition expression of disintegrin and metalloproteinase 17 (ADAM17) and p53 with subsequent inhibition of SARS-CoV-2-induced oxidative stress, neuroinflammation, and release of pro-inflammatory cytokines leads to inhibition of SARS-CoV-2-induced neuroinflammation
Fig. 4
Fig. 4
The possible role of citicoline in SARS-CoV-2-induced neuroinflammation: citicoline (CTN) activates the hypothalamic pituitary axis (HPA), acetylcholine (Ach), dopamine (DPM), silent information regulator 1 (SIRT1) and inhibits inflammation, oxidative stress, and glutamine release (Glu), leading to attenuation of SARS-CoV-2-induced neuroinflammation

Similar articles

Cited by

References

    1. Abbas M, Rahman S. Effects of alpha-7 nicotinic acetylcholine receptor positive allosteric modulator on lipopolysaccharide-induced neuroinflammatory pain in mice. Eur J Pharmacol. 2016;783:85–91. doi: 10.1016/j.ejphar.2016.05.003. - DOI - PubMed
    1. Abbaszadeh M, Rasooli R, Shadi Mazdaghani MS, Rajaian H, Shamsaei HA (2018) Pharmacokinetics of citicoline after intravenous and intramuscular administration in dogs. Vet Sci Develop. 1 Jan;8(1) 10.4081/vsd.2018.6945.
    1. Abdel-Aziz N, Moustafa EM, Saada HN. The impact of citicoline on brain injury in rats subjected to head irradiation. Environ Sci Pollut Res Int. 2021;28(8):9742–9752. doi: 10.1007/s11356-020-11101-7. - DOI - PubMed
    1. Abdel-Salam O, Youness ER, Mohammed NA, El-Moneim OM, Shaffie N. Citicoline protects against tramadol-induced oxidative stress and organ damage. React Oxygen Species. 2019;7(20):106–120. doi: 10.20455/ros.2019.823. - DOI
    1. Abdolmaleki A, Moghimi A, Ghayour MB, Rassouli MB. Evaluation of neuroprotective, anticonvulsant, sedative and anxiolytic activity of citicoline in rats. Eur J Pharmacol. 2016;789:275–279. doi: 10.1016/j.ejphar.2016.07.048. - DOI - PubMed

Substances

LinkOut - more resources